Chemical Identity and Biochemical Background

3,4-Dihydroxyphenylacetic acid (DOPAC; CAS 102-32-9) is a catechol-containing organic acid with the molecular formula C₈H₈O₄ and a molecular weight of 168.15 g/mol. It is one of the two principal metabolites of dopamine, the other being homovanillic acid (HVA). DOPAC is generated within dopaminergic neurons when dopamine is deaminated by monoamine oxidase (MAO), predominantly MAO-B in the human brain, yielding an aldehyde intermediate that is subsequently oxidized to DOPAC by aldehyde dehydrogenase.

Because DOPAC reflects intraneuronal dopamine turnover rather than synaptic release, the ratio of DOPAC to dopamine (DOPAC/DA ratio) is a widely accepted index of presynaptic dopamine metabolism and oxidative stress within dopaminergic terminals. Elevated DOPAC/DA ratios have been associated with increased MAO activity or impaired vesicular storage of dopamine, making DOPAC a sensitive neurochemical probe in models of Parkinson's disease, drug-induced dopaminergic changes, and neurotoxicity studies.

Storage, Stability, and Handling Recommendations

Storage conditions: DOPAC should be stored at –20 °C under inert atmosphere (argon or nitrogen) and protected from light. As a catechol, DOPAC is susceptible to oxidative degradation in the presence of oxygen, light, and alkaline conditions. Desiccation is recommended to prevent moisture-induced decomposition.

Stability in solution: Aqueous solutions of DOPAC are particularly prone to autoxidation, which is accelerated by neutral or basic pH and by trace metal ions. For greatest stability, prepare fresh solutions immediately before use in acidified water (e.g., 0.1 M perchloric acid or 0.01 M HCl) with the addition of an antioxidant such as sodium metabisulfite (Na₂S₂O₅, ~0.1% w/v) or ascorbic acid. Solutions should be kept on ice and used within hours of preparation.

Personal protective equipment: Wear appropriate laboratory gloves, eye protection, and a lab coat when handling DOPAC powder or solutions. Although DOPAC is an endogenous mammalian metabolite and not classified as acutely hazardous at research quantities, standard laboratory safety precautions apply. Consult the Safety Data Sheet (SDS) provided with the product for full hazard information.

Waste disposal: Dispose of DOPAC-containing waste in accordance with institutional and local regulations for organic chemical waste.

Solution Preparation and Common Analytical Applications

Stock solution preparation: Dissolve DOPAC in a minimum volume of acidified aqueous solution (0.1 M perchloric acid is standard for HPLC mobile-phase compatibility) to prepare a concentrated stock (e.g., 10 mM). Filter through a 0.22 µm membrane before use. For cell-based assays, DOPAC can also be dissolved in DMSO at higher concentrations; however, the DMSO vehicle concentration in the final assay medium should be kept ≤0.1% v/v to avoid cytotoxicity artifacts.

HPLC with electrochemical detection (HPLC-ECD): DOPAC is most commonly quantified alongside dopamine, norepinephrine, serotonin, and their metabolites using reversed-phase HPLC coupled to amperometric or coulometric electrochemical detection. Typical mobile phases are sodium phosphate or sodium acetate buffers (pH 2.5–3.5) with ion-pairing reagents and a small percentage of methanol or acetonitrile. DOPAC elutes before HVA on most C18 columns. As an analytical reference standard (Aladdin D106475), DOPAC is used to generate calibration curves and to verify detector response.

Tissue and microdialysis sample processing: Brain tissue samples for DOPAC measurement are typically homogenized in 0.1–0.4 M perchloric acid containing an internal standard (e.g., dihydroxybenzylamine, DHBA), centrifuged to remove protein, and the supernatant injected directly onto the HPLC column. Microdialysis perfusates can often be injected without further sample cleanup when an appropriate mobile phase is used.

Electrochemical biosensor and mass spectrometric methods: DOPAC is also measured by liquid chromatography–tandem mass spectrometry (LC-MS/MS) for high-sensitivity and high-specificity quantification in plasma, urine, and cerebrospinal fluid, using stable isotope-labeled internal standards where available.

Key Research Applications in Neuroscience

Dopaminergic system integrity assessment: DOPAC concentrations in striatal and limbic brain regions serve as established indices of dopamine synthesis, release, and catabolism. In rodent models of Parkinson's disease induced by 6-hydroxydopamine (6-OHDA) or MPTP, dramatic reductions in striatal DOPAC reflect dopaminergic terminal degeneration, whereas acute pharmacological challenges (e.g., L-DOPA administration, amphetamine) produce characteristic changes in DOPAC that are used to infer mechanisms of drug action.

Oxidative stress research: Because MAO-mediated dopamine catabolism to DOPAC generates hydrogen peroxide (H₂O₂) as a byproduct, elevated DOPAC production can contribute to oxidative stress within dopaminergic neurons. DOPAC itself can also undergo redox cycling and form reactive orthoquinones, implicating it in dopamine neurotoxicity research.

Pharmacological and toxicological screening: MAO inhibitors (MAOIs), catechol-O-methyltransferase (COMT) inhibitors, and vesicular monoamine transporter 2 (VMAT2) ligands all alter DOPAC levels in predictable ways, making DOPAC measurement a standard readout in preclinical CNS drug development and neurotoxicity screening.

Clinical and translational research: DOPAC can be measured in cerebrospinal fluid (CSF), urine, and plasma as a biomarker of central and peripheral dopaminergic function in conditions such as Parkinson's disease, schizophrenia, and neuroblastoma.

Quality, Purity, and Regulatory Considerations

Purity requirements: For quantitative analytical work, including HPLC calibration and mass spectrometric assays, reagent-grade DOPAC with documented purity ≥98% (by HPLC) is recommended to minimize interference from structurally related catechol impurities. A Certificate of Analysis (CoA) specifying purity, appearance, and identity confirmation (e.g., by NMR or mass spectrometry) should accompany each lot.

Lot-to-lot consistency: When conducting longitudinal studies or multi-site studies, researchers are advised to reserve sufficient material from a single lot to cover all experiments. Lot numbers should be recorded in laboratory notebooks and publications to ensure reproducibility.

Regulatory status: DOPAC is not a scheduled or controlled substance and does not require special permits for research use in most jurisdictions. It is intended for research use only (RUO) and is not approved for diagnostic or therapeutic use in humans or animals.

Aladdin product reference: Aladdin Scientific supplies DOPAC as catalog number D106475. Researchers should verify current specifications, purity grade, and available pack sizes by consulting the product page or contacting technical support prior to ordering.